Ignite Creation Date:
2024-05-06 @ 1:03 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03913234
Status:
UNKNOWN
Last Update Posted:
2022-05-10
First Post:
2019-04-10
Brief Title:
Phase IB II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR HER2 Advanced Breast Cancer Patients
Sponsor:
Yonsei University
Organization:
Yonsei University
Organization Data
Organization:
Yonsei University
Class:
OTHER
Study ID:
4-2018-0765
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yonsei University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None